Rachel McMinn is Founder and Chief Executive Officer of Neurogene Inc. (NGNE). The company reported total compensation of $3,209,553 for fiscal year 2025.
| Salary | $618,800 |
|---|---|
| Bonus | $371,280 |
| Stock awards | $385,746 |
| Option awards | $1,826,570 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $7,157 |
| Total | $3,209,553 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Neurogene Inc. filed April 16, 2026, accession 0001404644-26-000027.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Founder and Chief Executive Officer | $618,800 | $371,280 | $385,746 | $1,826,570 | $0 | $0 | $7,157 | $3,209,553 |
| FY2024 | Founder and Chief Executive Officer | $595,000 | $327,250 | $0 | $2,535,405 | $0 | $0 | $7,160 | $3,464,815 |
Totals as disclosed in each year's own compensation disclosure for Neurogene Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Rachel McMinn this page | Founder and Chief Executive Officer | $3,209,553 |
| Christine Mikail | President and Chief Financial Officer | $2,754,458 |
| Julie Jordan | Chief Medical Officer | $1,472,307 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Neurogene Inc. compensation brief.
Rachel McMinn's compensation sits inside Neurogene Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.